Any feedback?
Please rate this page
(all_enzymes.php)
(0/150)

BRENDA support

2.5.1.54: 3-deoxy-7-phosphoheptulonate synthase

This is an abbreviated version!
For detailed information about 3-deoxy-7-phosphoheptulonate synthase, go to the full flat file.

Word Map on EC 2.5.1.54

Reaction

phosphoenolpyruvate
+
D-erythrose 4-phosphate
+
H2O
=
3-deoxy-D-arabino-hept-2-ulosonate 7-phosphate
+
phosphate

Synonyms

2-dehydro-3-deoxy-D-arabino-heptonate-7-phosphate D-erythrose-4-phosphate-lyase (pyruvate-phosphorylating), 2-dehydro-3-deoxy-phosphoheptanoate aldolase, 2-dehydro-3-deoxy-phosphoheptonate aldolase, 2-keto-3-deoxy-D-arabino-heptonic acid 7-phosphate synthetase, 3-deoxy-7-phosphoheptulonate synthase, 3-deoxy-D-arabino heptulosonate 7-phosphate synthase, 3-deoxy-D-arabino-2-heptulosonic acid 7-phosphate synthetase, 3-deoxy-D-arabino-heptolosonate-7-phosphate synthetase, 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase, 3-deoxy-D-arabino-heptulosonate 7-phosphate synthetase, 3-deoxy-D-arabino-heptulosonate-7-phosphate synthase, 3-deoxy-D-arabino-heptulosonic acid 7-phosphate synthase, 3-deoxy-D-arabinoheptulosonate 7-phosphate synthase, 3-deoxy-D-arabinoheptulosonate-7-phosphate synthetase, 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate D-erythrose-4-phosphate-lyase (pyruvate-phosphorylating), 7-phospho-2-keto-3-deoxy-D-arabino-heptonate D-erythrose-4-phosphate lyase (pyruvate-phosphorylating), aldolase, phospho-2-keto-3-deoxyheptanoate, Aro1A, Aro4, Aro4p, AroA, AroA(Q), aroF, AroFFR, AroG, D-erythrose-4-phosphate-lyase, D-erythrose-4-phosphate-lyase (pyruvate-phosphorylating), DAH7-P synthase, DAH7-P synthase (phe), DAH7P, DAH7P synthase, DAH7PS, DAHP synthase, DAHP synthase-phe, DAHP synthase-trp, DAHP synthase-tyr, DAHP(Phe), DAHPS, DAHPS(Tyr), Dax1, deoxy-D-arabino-heptulosonate-7-phosphate synthetase, DHS, DHS1, DS-Co, DS-Mn, EC 4.1.2.15, KDPH synthase, KDPH synthetase, More, mtDAH7Ps, MtDS, NCgl0950 DAHP synthase, NCgl2098 DAHP synthase, Nme-DAH7PS, OsDAHPS, PF1690, phospho-2-dehydro-3-deoxyheptonate aldolase, phospho-2-keto-3-deoxyheptanoate aldolase, Phospho-2-keto-3-deoxyheptonate aldolase, phospho-2-keto-3-deoxyheptonic aldolase, phospho-2-oxo-3-deoxyheptonate aldolase, phzC, TmaDAH7PS

ECTree

     2 Transferases
         2.5 Transferring alkyl or aryl groups, other than methyl groups
             2.5.1 Transferring alkyl or aryl groups, other than methyl groups (only sub-subclass identified to date)
                2.5.1.54 3-deoxy-7-phosphoheptulonate synthase

Engineering

Engineering on EC 2.5.1.54 - 3-deoxy-7-phosphoheptulonate synthase

Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
PROTEIN VARIANTS
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
C145S
-
site-directed mutagenesis, 16% remaining activity compared to the wild-type, 4.6fold increased Km, 1.6fold decreased kcat, and 13.6fold decreased kcat/Km for phosphoenolpyruvate
C334S
-
site-directed mutagenesis, unaltered properties
C67L
-
site-directed mutagenesis, highly reduced activity, insensitive to inhibition by divalent metal ions
C67S
-
site-directed mutagenesis, inactive
S187A
-
site-directed mutagenesis, slightly reduced activity
S187C
-
site-directed mutagenesis, reduced activity, activation by tyrosine and phenylalanine instead of inhibition like the wild-type
S187F
-
site-directed mutagenesis, highly reduced activity, activation by tyrosine and phenylalanine instead of inhibition like the wild-type
S187Y
-
site-directed mutagenesis, highly reduced activity, activation by tyrosine and phenylalanine instead of inhibition like the wild-type
C328V
-
oligo-nucleotide mutagenesis, expression in Escherichia coli strains, 20% reduction in the catalytic constant, 2-3fold increase in Km for the substrates, completely resistant to both spontaneous and Cu2+-catalysed inactivation
C61A
DAHP oxime binding is noncompetitive with respect to Mn2+
C61G
-
site-directed mutagenesis, highly reduced activity, highly increased Km for phosphoenolpyruvate, higher pH-optimum than the wild-type
C61V
-
oligo-nucleotide mutagenesis, expression in Escherichia coli strains, inactive, does not bind metal ions, resistant to metal attack, no subunit dissociation upon Cu2+ treatment
D326A
DAHP oxime binding is noncompetitive with respect to Mn2+
DELTA1-15
-
N-terminal deletion of amino acids 1-15, no formation of dimeric form
E24Q
unlike tetrameric enzyme, mutant is dimeric in solution
F144A
-
inhibition by phenylalanine, 30% residual activity
F209A
-
inhibition by phenylalanine, 79% residual activity
H172G
-
site-directed mutagenesis, inactive
H207G
-
site-directed mutagenesis, reduced activity, increased Km values for the substrates, reduced kcat
H268A
DAHP oxime binding is competitive with respect to Mn2+
H268G
-
site-directed mutagenesis, inactive
H304G
-
site-directed mutagenesis, reduced activity, increased Km values for the substrates, increased kcat
H64G
-
site-directed mutagenesis, reduced activity, increased Km values for the substrates, increased kcat
H64L
-
oligo-nucleotide mutagenesis, expression in Escherichia coli strains, unstable to treatment with phosphoenolpyruvate, half-life of about 24 h at 0.4 mM compared to 6 days for the wild-type
I213P
overexpression of variant leads to less decrease in the accumulation of phenylalanine than overexpression of wild-type
L175A
-
inhibition by phenylalanine, 18% residual activity
L175D
-
inhibition by phenylalanine, 83% residual activity
L175Q
L179A
-
inhibition by phenylalanine, 82% residual activity
N8A
overexpression of variant leads to less decrease in the accumulation of phenylalanine than overexpression of wild-type
N8K
-
similar activity and substrate affinities like the wild-type, but insensitive against inhibition by tyrosine, decreased thermostability
P148A
overexpression of variant leads to less decrease in the accumulation of phenylalanine than overexpression of wild-type
P150L
-
inhibition by phenylalanine, no inhibition by phenylalanine
Q152A
overexpression of variant leads to higher accumulation of phenylalanine
S181A
overexpression of variant leads to higher accumulation of phenylalanine
V221A
-
inhibition by phenylalanine, 95% residual activity
W215A
-
inhibition by phenylalanine, 58% residual activity
I213P
-
overexpression of variant leads to less decrease in the accumulation of phenylalanine than overexpression of wild-type
-
N8A
-
overexpression of variant leads to less decrease in the accumulation of phenylalanine than overexpression of wild-type
-
P148A
-
overexpression of variant leads to less decrease in the accumulation of phenylalanine than overexpression of wild-type
-
Q152A
-
overexpression of variant leads to higher accumulation of phenylalanine
-
S181A
-
overexpression of variant leads to higher accumulation of phenylalanine
-
N8K
Escherichia coli W3110 / ATCC 27325
-
similar activity and substrate affinities like the wild-type, but insensitive against inhibition by tyrosine, decreased thermostability
-
R126S
site-directed mutagenesis, mutation of the residue involved in the salt bridge formation of Arg126-Glu27 results in perturbation of the less extensive interface in the enzyme tetramer and formation of enzyme dimers in solution. The dimeric NmeDAH7PSR126S variant exhibits a slight reduction in thermal stability by differential scanning calorimetry experiments and a slow loss of activity over time compared to the wild-type enzyme. Although NmeDAH7PSR126S crystallised as a tetramer, like the wild-type enzyme, structural asymmetry at the less extensive interface was observed consistent with its destabilisation
S213G
I181D
mutant enzyme is catalytically more active than the wild type enzyme from 20 to 80°C, the mutation disrupts the tetrameric structure of the enzyme, the melting temperatures of the wild-type protein are significantly higher than the melting temperatures of mutant enzyme I181D at pH values greater than 6.5
K229L
-
the mutation eliminates the L-tyrosine sensitivity
P165G
-
inhibited by tryptophan
Q302R
-
inhibited by tryptophan
S195A
-
inhibited by tryptophan
H29A
site-directed mutagenesis, the mutant is inhibited by both L-Tyr and L-Phe
H29S/S31H
site-directed mutagenesis, the mutant is inhibited to a greater extent by L-Phe than L-Tyr
S31G
site-directed mutagenesis, the mutation severely reduces inhibition by L-Tyr
additional information